
|Videos|April 26, 2022
ViaLase shares updates on new technology to treat glaucoma, company updates and upcoming trials
Author(s)Kassi Filkins
Tom Frinzi, executive chairman of ViaLase, a new company based in Orange County, gives an update on the company, sharing some exciting new things happening.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Kala Bio's CHASE trial misses primary endpoint, KPI-012 development discontinued
2
Q&A: Patricio Schlottmann discusses results of AVONELLE-X faricimab extension trial
3
Researchers assess atropine and cyclopentolate for detecting premyopia in young children
4
Q&A: Alexandra Miere discusses the ACTOR and HERMES studies
5